Asklepios Enters Cross-License Agreement with Genzyme Asklepios BioPharmaceutical, Inc. today announced that it has entered into a non-exclusive cross-license agreement with Genzyme, a Sanofi company, in which Genzyme receive
July 16, 2013 - Business Wire via Yahoo! Finance
Marlee Matlin in Washington Post All partners contribute their particular core competencies: Tongji University adds its medical and scientific know-how, Siemens its combined expertise in structured finance, clinical workflow, and hospital technology solutions and Asklepios... Johannes Schmidt http://www.google.com/url?q=http://en.wikipedia.org/wiki/Johannes_Schmidt_(linguist)&source=dictionary&usg=AFQjCNEWmQfu2TZo-xHSqwmbnQHNPKPg9g WebWire (press release) http://www.google.com/url?q=http://www.webwire.com/ViewPressRel.asp%3FaId%3D37425&source=dictionary&usg=AFQjCNE644heh5IOZIj6BjxEulpXPuQP6g May 27, 2007
5828 8671 asl For Sweet Nothing in My Ear," Matlin said, she "had to have a dialogue coach who made sure I performed the ASL correctly."